Clinical Trials Logo

Citation(s)

Phase 2 Study With the Multi-Targeted Tyrosine-Kinase Inhibitor Pazopanib (GW786034) for Patients With Relapsed or Refractory Urothelial Cancer

Details for clinical trial NCT01031875